HANNAH MIDYETT: Open Payments
NPI 1306394218 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 14 payments from 8 companies in 2025. Trend: 2023 $301 · 2024 $398 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $209 |
| GlaxoSmithKline, LLC. | 3 | $147 |
| Inspire Medical Systems, Inc. | 3 | $145 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $110 |
| Viatris Specialty LLC | 2 | $86 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: ZEPBOUND, NUCALA, INSPIRE, UPTRAVI, AIRSUPRA, YUPELRI, FUROSCIX.
Industry payments across LA — which companies pay providers there.
